Skip to main content
    N

    Novartis AG ADR (NVS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $160.21
    -0.29 (-0.18%)

    Market Cap: $303.12B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Novartis AG ADR (NVS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Novartis AG ADR are Novo Nordisk A/S (NVO), AstraZeneca (AZN) and Merck & Company (MRK). Novartis AG ADR trades at 18.7x earnings, against a median of 22.5x for the 9 of these companies with a P/E. By market cap, Novartis AG ADR ranks 5th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T.

    Peer Comparison

    NVS's ROIC of 13.5% is below the peer median of 13.9%, and its revenue growth of 4.7% is below the median of 6.8%. Its dividend yield is above the peer median of 2.35%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Eli Lilly and Company (LLY)$1.29T44.9x14.8x31.9%30.7%38.6%0.48%
    Peer median$230.18B22.5x5.0x15.9%13.9%6.8%2.35%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Novartis AG ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Johnson & Johnson (JNJ)
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Eli Lilly and Company (LLY)
    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
    LLY competitors

    Frequently Asked Questions About NVS

    Who are Novartis AG ADR's main competitors?

    The companies most similar to Novartis AG ADR include Novo Nordisk A/S (NVO), AstraZeneca (AZN), Merck & Company (MRK), Amgen (AMGN) and Sanofi ADR (SNY), listed from the closest match.

    Who is Novartis AG ADR's biggest competitor?

    Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; Novo Nordisk A/S (NVO) is the closest match by business profile, size, sector and industry.

    How does NVS stock compare with its competitors?

    NVS' P/E is 18.7x against a peer median of 22.5x; its P/S is 5.4x against a peer median of 5.0x; its net margin is 17.5% against a peer median of 15.9%.

    Which of Novartis AG ADR's competitors pays a higher dividend?

    Novartis AG ADR has a forward dividend yield of 2.98%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY) and GSK (GSK) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Novartis AG ADR bigger than its competitors?

    No. Novartis AG ADR is 5th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.